Semiconducting Open‐Shell Radicals for Precise Tumor Activatable Phototheranostics
Semiconducting open-shell radicals (SORs) have promising potential for the development of phototheranostic agents, enabling tumor bioimaging and boosting tumorous reactive oxygen species (ROS). Herein, a new class of semiconducting perylene diimide (PDI), designated as PDI(Br)<sub>n</sub> with various numbers of bromine (Br) atoms modified on PDI's bay/ortho positions is reported. PDI(Br)<sub>n</sub> is demonstrated to transform into a radical anion, [PDI(Br)<sub>n</sub>]<sup>•-</sup>, in a reducing solution, with a typical g-value of 2.0022. Specifically, [PDI(Br)<sub>4/6</sub>]<sup>•-</sup> is generated in the weakly reductive tumor-mimicking solution and exhibits high stability in air. Quantum chemical kinetic simulation and ultrafast femtosecond transient absorption spectroscopy indicate that [PDI(Br)<sub>6</sub>]<sup>•-</sup> has a low π-π stacking energy (0.35 eV), a fast electron transfer rate (192.4 ps) and energy gap of PDI(Br)<sub>6</sub> (ΔE<sub>S1, T1 </sub>= 1.307 eV, ΔE<sub>S1, T2 </sub>= 0.324 eV) respectively, which together result in excited-state charge transfer characters. The PDI(Br)<sub>6</sub> nanoparticle radicals, [PDI(Br)<sub>6</sub>] NPs<sup>•-</sup>, specifically enable chemodynamic and type-I photodynamic ROS generation in tumors, including superoxide and hydroxyl radicals, which elicit immunogenic cell death effect. Also, [PDI(Br)<sub>6</sub>] NPs<sup>•-</sup> facilitate activatable bioimaging-guided therapy due to their photoacoustic signal at 808 nm and NIR-II emission at 1115 nm. The work paves the way for the design of SORs for precise cancer theranostics.
Authors
- Weijie Chi (ORCID: https://orcid.org/0000-0003-1776-0025)
- Fengwei Sun
- Zhèn Yáng (ORCID: https://orcid.org/0000-0003-4056-0347)
- Bo Wang (ORCID: https://orcid.org/0000-0001-9092-3252)
- Jie Zhang (ORCID: https://orcid.org/0000-0002-5449-9412)
- Jingqi Lv
- Zhu-ting Fang (ORCID: https://orcid.org/0000-0003-3350-2210)
- Wen Ma (ORCID: https://orcid.org/0009-0004-9510-7579)
- Haifen Luo
Institutions
- Fujian Normal University (CN)
- Fujian Medical University (CN)
- Hainan University (CN)
- Fujian Provincial Hospital (CN)
- Fujian Provincial Cancer Hospital (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- Advanced Science
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1002/advs.202500293
- Citations
- 7
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 4.72
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- National Key Research and Development Program of China
- Fujian Provincial Health Technology Project